PREVYMIS 240 mg/1
LETERMOVIR · TABLET, FILM COATED · Merck Sharp & Dohme LLC
No Recall History
Plain English
PREVYMIS is a tablet, film coated containing letermovir at 240 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- PREVYMIS
- Generic Name
- LETERMOVIR
- NDC Code (Product)
0006-3075- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 240 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209939
- Drug Class
- Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
- Marketing Start
- 11/08/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is PREVYMIS used for?
PREVYMIS contains LETERMOVIR. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is PREVYMIS a controlled substance?
PREVYMIS is not classified as a controlled substance by the DEA.
What is the generic name for PREVYMIS?
The generic name for PREVYMIS is LETERMOVIR. There are no other listed brand versions of LETERMOVIR.
What is the NDC code for PREVYMIS 240 mg/1?
The NDC (National Drug Code) for PREVYMIS 240 mg/1 is 0006-3075, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)